News on Medial

PlasmaGen Biosciences raises Rs 150 Cr led by ViNS Bioproducts

EntrackrEntrackr · 20d ago
PlasmaGen Biosciences raises Rs 150 Cr led by ViNS Bioproducts
Medial

Snippets PlasmaGen Biosciences raises Rs 150 Cr led by ViNS Bioproducts Bengaluru-based biopharma company PlasmaGen Biosciences has raised Rs 150 crore led by ViNS Bioproducts along with participation from high-net-worth individuals, family offices, pharma entrepreneurs, and existing investors. The startup is backed by Eight Road Ventures secured the funding at a valuation of over Rs 1,500 crore. PlasmaGen has mopped up over Rs 600 crore in funding to date from Fidelity's FIL Capital Investments, Eight Roads Ventures, F-Prime Capital, and others. The proceeds will be used to scale international operations, expand the product portfolio, and strengthen manufacturing and leadership capabilities, PlasmaGen Biosciences said in a press release. Founded in 2010, PlasmaGen Biosciences focuses on producing and marketing plasma-derived therapies like Immunoglobulin, Albumin, and clotting factors to bridge India's demand-supply gap for these critical medicines, operating a modern fractionation plant in Kolar, Karnataka, and serving neurology, hematology, and critical care, aiming for self-reliance in plasma products. According to PlasmaGen, it has identified distribution partners in key export geographies and is in the process of securing regulatory approvals to begin international sales. India continues to remain a key market for the firm, which is expanding its services across hospitals and physicians through a cold-chain-backed distribution network. PlasmaGen says that it began commercial operations in 2024 at its plasma fractionation facility in Kolar, near Bengaluru. The company asserts that the setup is among only five such facilities in the country and claims that it is the first pure-play plasma biopharma player, has reported strong revenue growth since launch of operations at Kolar and is now preparing to enter overseas markets.

Related News

Exclusive: Atomberg raises Rs 212 Cr in Series C extension led by Temasek

EntrackrEntrackr · 1m ago
Exclusive: Atomberg raises Rs 212 Cr in Series C extension led by Temasek
Medial

Exclusive: Atomberg raises Rs 212 Cr in Series C extension led by Temasek Consumer appliances brand Atomberg has secured Rs 212 crore ($24 million) in an extension of its Series C round led by Jongsong Investments (Temasek), with participation from its co-founders and existing backers. As per regulatory filings sourced from the Registrar of Companies (RoC), the board approved the issuance of 10,006 Series C1 and C2 preference shares at Rs 2,11,835 per share to raise the fresh capital. Temasek led the tranche with an infusion of Rs 132 crore, while Jungle Ventures and Inflexor Fund contributed Rs 17.8 crore and Rs 17.9 crore, respectively. Co-founders Manoj Kumar Meena and Sibabrata Das together invested Rs 44 crore during this round. This appears to be part of a larger ongoing funding round, and Atomberg is expected to raise additional capital for the secondary transactions. As per Entrackr’s estimates, the latest allotment values the company at around $500 million post-money. With this, Atomberg has raised over $150 million to date, including the $86 million Series C round led by Temasek and Steadview Capital in May 2023. Sibabrata Das, co-founder of Atomberg, declined to comment on the queries sent by Entrackr. Founded in 2012 by Meena and Das, Atomberg has built a strong R&D-led product portfolio featuring energy-efficient BLDC and smart fans, mixer grinders, and smart locks. The brand claims a retail footprint spanning more than 15,000 touchpoints across India. Atomberg initially entered the market in 2015, catering to B2B customers such as the Tata Group, Infosys, and Indian Railways before expanding into B2C via Flipkart and Amazon, and later scaling offline distribution from 2018 onward. The company is yet to file its FY25 financials. In FY24, its revenue from operations grew 31% year-on-year to Rs 848 crore, while losses narrowed by 31.7% during the same period.

Exclusive: Rebel Foods raises Rs 150 Cr debt from Alteria and InnoVen

EntrackrEntrackr · 3m ago
Exclusive: Rebel Foods raises Rs 150 Cr debt from Alteria and InnoVen
Medial

Exclusive: Rebel Foods raises Rs 150 Cr debt from Alteria and InnoVen Foodtech Unicorn Rebel Foods secured Rs 150 crore ($17 million) in debt funding from existing investors Alteria Capital and InnoVen Capital. The debt comes months after its $25 million funding from Qatar Investment Authority. According to its filing sourced from the Registrar of Companies (RoC), Rebel Foods’ board approved the allotment of 15,000 non-convertible debentures (NCDs) at a face value of Rs 1 lakh each to raise the above-mentioned amount. Alteria Capital invested Rs 90 crore ($10.2 million), while InnoVen Capital contributed Rs 60 crore ($6.8 million). Each debenture carries a coupon rate of 13.9% per annum with a tenure of three years, maturing on September 2, 2028. Rebel Foods declined to comment on the queries sent by Entrackr. Founded in 2011 as a quick-service restaurant, Rebel Foods has grown into one of the largest cloud kitchen operators, with over 450 kitchens across India, the MENA region, Indonesia, the UK, and 75 Indian cities. Its portfolio includes brands such as Faasos, Behrouz Biryani, Oven Story Pizza, Lunchbox, The Good Bowl, and Wendy’s, among others. In February this year, Rebel Foods announced that it had launched its 15-minute food delivery app, QuickiES. According to TheKredible, the Mumbai-based firm has raised approximately $780 million to date, including a $210 million Series G round led by Temasek, comprising a mix of primary and secondary stake. Rebel Foods’ revenue from operations grew to Rs 1,420 crore in FY24 as compared to Rs 1,195 crore in FY23. During the same period, the firm cut down its losses by over 42% to Rs 378 crore. It competes with Curefoods, EatClub, Biryani By Kilo, FreshMenu, Biryani Blues, Kitchens@, Bigspoon, and HOI Foods.

Download the medial app to read full posts, comements and news.